Fierce Healthcare

Optimizing Wound Management: Clinical Evidence, Real-World Data, and Cost Benefits of Collagenase SANTYL Ointment

Recent research is revealing key insights about the therapeutic potential of clostridial collagenase. Join us for this upcoming webinar to learn about new data on SANTYL® ointment’s unique mechanisms ...
Yahoo Finance

MediWound Announces Positive Results in Head-to-Head Comparison of EscharEx® vs. SANTYL® within the ChronEx Phase II Randomized Controlled Study

YAVNE, Israel, Feb. 12, 2024 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), the global leader in next-generation enzymatic therapeutics for tissue repair today announced the results of ...
Yahoo Finance

MediWound Announces Publication of Phase II EscharEx® Data Demonstrating Superiority Over Collagenase in Venous Leg Ulcers

YAVNE, Israel, May 13, 2025 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a global leader in next-generation enzymatic therapeutics for tissue repair, today announced the publication of a ...
Mena FN

Santyl Global Market Report 2025: Significant Growth Expected Amid Rising Chronic Wound Cases

Santyl Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 The Business Research Company's Santyl Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 Updated 2025 ...
Nasdaq

MediWound Announces Publication of Phase II EscharEx® Data Demonstrating Superiority Over Collagenase in Venous Leg Ulcers

Post hoc analysis published in the peer-reviewed journal Wounds highlights EscharEx®’s superior clinical performance and comparable safety profile to SANTYL® “These new findings are consistent with my ...